News + Insights

What Surprised an Academic About Drug Development Drug development is complicated. It requires many different skills and many people working together. No one can make a drug alone.
Daria Mochly-Rosen, PhD
Welcome to SPARK NS News + Insights!
Stephen Kargotich, PhD, MBA, LLB
Starting with the End in Mind
Opher Kornfeld, PhD
Breaking Barriers in Neuroscience Translational Research
Ariella Bersan
Identifying Unmet Medical Need
Kevin Grimes, MD, MBA
How Stakeholder Input Shapes Better Therapies
Danielle Gerhard, PhD
Impact of SPARK NS on Academic Research
Ariella Bersan

Spotlight

Miratul Muqit, MBChB, PhD: A Study In PINK

Parkinson’s researcher pursues therapies that can prevent the loss of brain cells that will slow or stop the progression of the disease.

Spotlight

Miratul Muqit, MBChB, PhD, University of Dundee & UK Dementia Research (UK DRI) Institute Parkinson’s Research Centre

Get Involved

Learn About Our Translational Research Program

The SPARK NS program is based on a unique model of translational research with an exceptional 50% success rate at guiding discoveries from the lab to the clinic.

LearnMore

Apply Now for Our Free Upcoming Short Course

Autism and Parkinson's PIs in the US & Canada, join us at the SPARK NS short course, “Positioning Neuroscience Discoveries for Successful Drug Development," February 25-27, 2026, in the San Francisco Bay Area.

LearnMore

Sign Up for Updates

Sign up for updates about our next Call for Proposals for the SPARK NS Translational Research Program, short courses on drug development and academic entrepreneurship, and other opportunities.

SignUp